Pain Management
Conditions
Interventions
This is a randomized, controlled clinical trial in a parallel, and double-blind model. The evaluating researchers and the participants will not know which group each participant belongs. Forty patient
CTR: Use of placebo oil starting at the time of the surgical procedure and for 5 days after the surgical procedure. Patients will be clinically analyzed in periods of 3, 7, 15 and 30 days after tooth
Sponsors
Universidade Federal de Uberlândia
Universidade Federal de Uberlândia
Eligibility
Age
18 Years to 60 Years
Inclusion criteria
Inclusion criteria: Patients of both genders. aged between 18 and 60 years. who are systemically healthy and who require surgery to remove the four third molars
Exclusion criteria
Exclusion criteria: Patients using drugs acting on the central nervous system. decompensated diabetics (glycated hemoglobin above 8%). consumption of any medication 15 days prior to inclusion in this study, patients with hypersensitivity to the drugs to be used in postoperative care, pregnant women or during lactation. chronic smokers and alcoholics. presence of periapical lesions. presence of pericoronitis lesions
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The use of cannabinoid will reduce the painful sensation by 2 points on the visual analogue pain perception scale and will reduce the consumption of analgesics and anti-inflammatories by 10% in the postoperative phase of third molar extractions compared to the placebo group. | — |
Secondary
| Measure | Time frame |
|---|---|
| The use of cannabinoid will reduce edema by 10%, and will improve soft tissue healing by 10% in the postoperative phase of third molar extractions compared to the placebo group. | — |
Countries
Brazil
Contacts
Public ContactGuilherme Oliveira
Universidade Federal de Uberlândia
Outcome results
None listed